ANNOUNCED AS TEMPORARYNo
The regulation includes the provision that the pharmaceutical and medical equipment industries shall prioritise the use of local raw materials (article 6(1)).
There are no clear rules on what percentage the local content requirements shall be set. However, there are some indications in the appendix of the regulation: for instance, during the research and development stage, the content shall be at least 25% (p.82). In the production process, the content shall be at least 35%.
Furthermore, the regulation mentions reducing the current import market share from 94% to 45% by 2035 (p.79).
In general, the pharmaceutical industry shall be developed using three strategies:
The regulation came into force on 28 February 2017.
⚑ Please report this page in case you detect an inaccuracy in its content.